Health Catalyst, Inc. current report, 12 February 2020

Business Context and Reporting Period

This Form 8-K was filed by Health Catalyst, Inc. on February 13, 2020, reporting an event that occurred on the same date. The filing details the execution of an acquisition agreement to purchase Able Health, Inc., a Delaware corporation.

Key Financial Metrics and Transaction Details

  • Acquisition Price: Aggregate purchase price of $27 million, plus a potential earnout.
  • Equity Consideration: 290,073 shares of Health Catalyst Common Stock to be issued to Able Health stockholders upon closing.
  • Earnout Provision: Up to $5 million in additional value contingent on performance targets met by December 31, 2020.
  • Valuation Basis: Earnout shares valued at $34.4741 per share (35-day average trading price ended February 7, 2020).
  • Maximum Earnout Shares: Approximately 145,036 shares if maximum targets are met.
  • Financial Impact: Management does not expect a material impact on 2020 GAAP revenue or adjusted EBITDA.

Material Changes and Outlook

The primary material change is the strategic acquisition of Able Health. The transaction is subject to customary closing conditions and is expected to close in the first quarter of 2020. Management indicated that further details regarding the financial impact would be provided during the Q4 2019 earnings call.

Risks and Contingencies

  • Closing Risk: The transaction is subject to customary closing conditions and may not be completed.
  • Integration Risk: Risks related to the successful integration of the two companies.
  • Market Conditions: Adverse and unpredictable macro-economic conditions could affect the transaction.
  • Forward-Looking Statements: Actual results may differ materially from expectations due to various uncertainties.

Investor Verification Checklist

  • Confirm the final closing date of the acquisition in Q1 2020.
  • Verify the actual number of earnout shares issued based on Able Health's performance through December 31, 2020.
  • Review the Q4 2019 earnings call transcript for specific details on the integration plan and financial impact.
  • Monitor for any updates regarding the vesting schedule of the unvested portion of the initial equity consideration.